Israeli artificial intelligence (AI) software developer Aidoc has received the CE Mark for AI software that can spot an incidental pulmonary embolism (PE) on contrast-enhanced CT exams and triage these cases for priority review.
The software can flag incidental PEs on scheduled or emergency contrast-enhanced CT scans, enabling sharp reductions in turnaround time for these cases, according to Aidoc. The company believes that the software, along with its other AI triage offerings, can help provide a safety net to healthcare systems for the expected surge of elective medical imaging exams that were delayed due to the COVID-19 pandemic.
![A normal mammogram confirmed by three-year radiologic follow-up illustrates reader-marked regions of interest (ROIs) during (A) unaided (round 1) and (B) artificial intelligence (AI)–assisted (round 2) reading. Each colored dot represents an ROI for recall by a human reader. Readers could mark more than one ROI per case, represented by multiple dots of the same color. During AI-assisted reading, the AI system displayed three visible prompts: two with suspicion of malignancy scores of 35% (left mediolateral oblique [L MLO] and craniocaudal [L CC]) and one with a suspicion of malignancy score of 10% (right craniocaudal [R CC]), shown as polygonal overlays. Without AI, six of 10 readers (60%) marked a false-positive ROI. With AI assistance, this fell to two of 10 (20%). R MLO = right mediolateral oblique.](https://img.auntminnieeurope.com/mindful/smg/workspaces/default/uploads/2026/07/2026-07-14-radiology-mammogram-ai-auto-bias.H0bYO8QlWs.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
